SCHEMBL7929690

SCHEMBL7929690

NCc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C(N)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ALOX12 P18054 1/20 0.41
ADRA1A P35348 1/20 0.41
DNMT1 P26358 4/20 0.41
TK1 P04183 3/20 0.41
ADRB1 P08588 1/20 0.41
TK2 O00142 1/20 0.41
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
TSHR P16473 1/20 0.38
BLM P54132 1/20 0.38
PMP22 Q01453 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
PIM1 P11309 1/20 0.36
CSNK2A2 P19784 1/20 0.36
CSNK2B P67870 1/20 0.36
CSNK2A1 P68400 1/20 0.36
CSNK2A3 Q8NEV1 1/20 0.36
DNMT3B Q9UBC3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8625601 0.90 LMNA (0.46) LMNASMN1; SMN2ALOX12ADRA1ADNMT1
SCHEMBL7928080 0.81 LMNA (0.37) LMNASMN1; SMN2ALOX12ADRA1ADNMT1
SCHEMBL149648 0.73 ADRB1 (0.50) LMNASMN1; SMN2ALOX12ADRA1ADNMT1
SCHEMBL2193016 0.73 ADRB1 (0.50) LMNASMN1; SMN2ALOX12ADRA1ADNMT1
SCHEMBL5983020 0.73 TK1 (0.69) LMNASMN1; SMN2ALOX12ADRA1ATK1
SCHEMBL5983012 0.73 TK1 (0.69) LMNASMN1; SMN2ALOX12ADRA1ATK1
SCHEMBL15285228 0.73 TK1 (0.69) LMNASMN1; SMN2ALOX12ADRA1ATK1
SCHEMBL27093305 0.70 DNMT1 (0.61) LMNASMN1; SMN2DNMT1TK1ADRB1
SCHEMBL5983240 0.70 DNMT1 (0.61) LMNASMN1; SMN2DNMT1TK1ADRB1
SCHEMBL5983245 0.70 DNMT1 (0.61) LMNASMN1; SMN2DNMT1TK1ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6239159-B1 SUBSTRATES FOR POLYMERASE AND TERMINAL TRANSFERASE ENZYMES. CAPABLE OF BASE-PAIRING WITH A NUCLEOTIDE RESIDUE IN A COMPLEMENTARY CHAIN OR BASE STACKING IN THE APPROPRIATE NUCLEIC ACID CHAIN, ADVANTAGE OVER CONVENTIONAL HAPTEN AMERSHAM PHARMACIA BIOTECH UK LIMITED (GB) 2001-05-29 US disclosed
EP-0885235-A1 NUCLEOSIDE ANALOGUES Amersham Pharmacia Biotech UK Limited (GB) 1998-12-23 EP disclosed
WO-1997028176-A1 NUCLEOSIDE ANALOGUES AMERSHAM PHARMACIA BIOTECH UK LIMITED (GB) 1997-08-07 WO disclosed